Table 2.
Clinical preoperative characteristics of the three patient categories.
| Group A | Group B | Group C | ||||
|---|---|---|---|---|---|---|
| Median | IQR | Median | IQR | Median | IQR | |
| Age (y) | 27.5 | 5.0 | 37.5 | 24.3 | 37.0 | 14.8 |
| BMI (kg/m2) | 26.1 | 3.3 | 27.2 | 2.9 | 25.9 | 6.1 |
| Preoperative LDH (U/L) | 244.0 | 107.0 | 246.0 | 76.0 | 172.5 | 43.5 |
| Preoperative AFP (µg/L) | 3.1 | 2.7 | 3.8 | 1.9 | 2.7 | 1.5 |
| Preoperative B-HCG (U/L) | 1.2 | 0.2 | 1.9 | 0.8 | 1.2 | 0.0 |
| size of retroperitoneal mass (cm) | 1.7 | 1.3 | 2.4 | 1.9 | 2.1 | 2.7 |
| post-chemotherapy, n | ||||||
| no | 8 | 5 | 5 | |||
| yes | 2 | 5 | 5 | |||
| Clinical stage (UICC) at time of RPLND, n | ||||||
| I | 0 | 1 | 0 | |||
| IIA | 4 | 3 | 2 | |||
| IIB | 6 | 5 | 8 | |||
| IIC | 0 | 1 | 0 | |||